#1
| |||
| |||
alexion pharmaceuticals inc annual report |
#3
| |||
| |||
Re: alexion pharmaceuticals inc annual report
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). Here I am attaching a pdf file of report .alexion.com/2016-Annual-Report/full-report/ Alexion Pharmaceuticals share price (17 may 2017) Open $120.75 Day Range 119.8500 - 121.0950 52 Week Range 109.1200 - 157.0200 Market Cap $27.16B Shares Outstanding 224.56M Public Float 223.24M Beta 1.48 Rev. per Employee $1.03M P/E Ratio 57.56 EPS $2.09 Yield n/a Dividend n/a Ex-Dividend Date n/a Short Interest 4.52M % of Float Shorted 2.03% Average Volume 2.01M Performance 5 Day -0.54% 1 Month -0.16% 3 Month -8.86% YTD -1.68% 1 Year -15.48% |
|